The Prognostic Value of Plasma YKL-40 in Patients With Chemotherapy-Resistant Ovarian Cancer Treated With Bevacizumab.
Int J Gynecol Cancer
; 26(8): 1390-8, 2016 10.
Article
in En
| MEDLINE
| ID: mdl-27648712
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Neoplasms, Glandular and Epithelial
/
Bevacizumab
/
Chitinase-3-Like Protein 1
/
Antineoplastic Agents, Immunological
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
Language:
En
Journal:
Int J Gynecol Cancer
Journal subject:
GINECOLOGIA
/
NEOPLASIAS
Year:
2016
Document type:
Article
Affiliation country:
Country of publication: